Cala Health Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
114
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$50M
- Investors
-
38
Cala Health General Information
Description
Developer of neuromodulation devices designed to optimize the standard of care for chronic diseases. The company's wearable device merges innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, enabling patients to reduce tremors and ensure relief.
Contact Information
Website
www.calahealth.comCorporate Office
- 1800 Gateway Boulevard
- Suite 120
- San Mateo, CA 94404
- United States
Corporate Office
- 1800 Gateway Boulevard
- Suite 120
- San Mateo, CA 94404
- United States
Cala Health Timeline
Cala Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | 20-Apr-2026 | $50M | Completed | Generating Revenue | ||
| 11. Mezzanine | 24-Feb-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C) | 25-Mar-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series BB) | Completed | Generating Revenue | ||||
| 8. Later Stage VC (Series D) | 16-Nov-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 21-May-2019 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Early Stage VC (Series B) | 16-Feb-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 02-Jul-2014 | $3.3M | $3.3M | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | Completed | Startup |
Cala Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-2 | ||||||||
| Series C-1 | ||||||||
| Series BB-2 | ||||||||
| Series BB-1 | ||||||||
| Series AA-4 | ||||||||
| Series AA-3 | ||||||||
| Series AA-2 | 26,267,156 | $0.000100 | $0.08 | $1.04 | $1.04 | 1x | $0.33 | 18.15% |
| Series AA-1 | 8,208,955 | $0.000100 | $0.03 | $0.4 | $0.4 | 1x | $0.33 | 2.19% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cala Health Comparisons
Industry
Financing
Details
Cala Health Competitors (49)
One of Cala Health’s 49 competitors is Neuspera, a Venture Capital-Backed company based in San Jose, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuspera | Venture Capital-Backed | San Jose, CA | ||||
| Allevion Therapeutics | Venture Capital-Backed | Irvine, CA | ||||
| Varian Medical Systems | Venture Capital-Backed | Palo Alto, CA | ||||
| Neuromonics | Formerly VC-backed | Calabasas, CA | ||||
| ShiraTronics | Venture Capital-Backed | Minneapolis, MN |
Cala Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cala Health Patents
Cala Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023365099-A1 | Neuromodulation devices and methods | Pending | 19-Oct-2022 | ||
| EP-4605068-A2 | Neuromodulation devices and methods | Pending | 19-Oct-2022 | ||
| EP-4605068-A4 | Neuromodulation devices and methods | Pending | 19-Oct-2022 | ||
| JP-2025535245-A | Neuromodulation devices and methods | Pending | 19-Oct-2022 | ||
| US-20260199678-A1 | Neuromodulation devices and methods | Pending | 19-Oct-2022 | A61N1/36036 |
Cala Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cala Health Investors (38)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eagle Point Trinity Senior Secured Lending Company BDC | Mezzanine | Minority | ||
| Trinity Capital Inc BDC | Business Development Company | Minority | ||
| Alumni Ventures | Venture Capital | Minority | ||
| Kirin Health Innovation Fund | Corporate Venture Capital | Minority | ||
| Octant Ventures | Venture Capital | Minority |
Cala Health FAQs
-
When was Cala Health founded?
Cala Health was founded in 2013.
-
Where is Cala Health headquartered?
Cala Health is headquartered in San Mateo, CA.
-
What is the size of Cala Health?
Cala Health has 114 total employees.
-
What industry is Cala Health in?
Cala Health’s primary industry is Therapeutic Devices.
-
Is Cala Health a private or public company?
Cala Health is a Private company.
-
What is Cala Health’s current revenue?
The current revenue for Cala Health is .
-
How much funding has Cala Health raised over time?
Cala Health has raised $339M.
-
Who are Cala Health’s investors?
Eagle Point Trinity Senior Secured Lending Company BDC, Trinity Capital Inc BDC, Alumni Ventures, Kirin Health Innovation Fund, and Octant Ventures are 5 of 38 investors who have invested in Cala Health.
-
Who are Cala Health’s competitors?
Neuspera, Allevion Therapeutics, Varian Medical Systems, Neuromonics, and ShiraTronics are some of the 49 competitors of Cala Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
